Aaron Bradley Parrish, MD
Colorectal Surgery (Proctology) · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 27
- 7 carriers
- Office
- 1
On the public record
- Owns National Ambulatory Surgery Center, LLC.: Accreditation Revoked
Offices
1 location
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
27 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Parrish’s office at (408) 478-6750 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Aetna Medicare Enhanced (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced Extra (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A128270 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- National Ambulatory Surgery Center, LLC.Ambulatory Surgery Center · Los Angeles, CA2% owner since 2024 · accredited by AAAHCAccreditation Revoked2 inspections, 1 with deficiencies · last 2025-07-30
- National Ambulatory Surgery Center LLCAmbulatory Surgery Center · Los Angeles, CA1.44% owner since 2025 · accredited by AAAASFInitial Accreditation1 inspection, 1 with deficiencies · last 2025-10-07
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$116,179
Medicare paid this office $116,179 for 310 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $17,352 | $207 |
| Return visit (30+ min) | 74 | $10,822 | $114 |
| New patient visit (30+ min) | 110 | $10,408 | $95 |
| New patient visit (45+ min) | 67 | $9,615 | $144 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $7,174 | $199 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $17,352 | $207 |
| Return visit (30+ min) | 74 | $10,822 | $114 |
| New patient visit (30+ min) | 110 | $10,408 | $95 |
| New patient visit (45+ min) | 67 | $9,615 | $144 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $7,174 | $199 |
| Biopsy of large bowel using a flexible endoscope | 83 | $6,574 | $79 |
| Removal of external hemorrhoids by rubber banding | 15 | $5,202 | $274 |
| Diagnostic exam of anus using an endoscope | 34 | $4,409 | $122 |
| Injection of hemorrhoid | 12 | $3,755 | $313 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,080 | $192 |
| Short return visit (20+ min) | 25 | $1,936 | $69 |
Procedures Medicare counted
| Colonoscopy | 253 | More than 96% of doctors who do this |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
310 Original Medicare patients in 2024. Average age 74 · Women 46% · Also on Medicaid 5% · Health risk score 0.98. At or below the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 1.44.
Conditions among them: High blood pressure 65% · Coronary heart disease 23% · Cancer 23% · Diabetes 20% · Atrial fibrillation 16% · Chronic kidney disease 13% · Depression 10% · Heart failure 7% · Stroke 6% · COPD 5% · Dementia 5%.
The office billed $796,986, Medicare allowed $150,554 and paid $116,179; for 692 services of 56 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 310 | 692 | 74 | 0.98 | $796,986 | $116,179 |
| 2023 | 368 | 858 | 74 | 0.89 | $964,450 | $143,278 |
| 2022 | 372 | 952 | 75 | 0.93 | $1,095,648 | $142,939 |
| 2021 | 309 | 726 | 74 | 0.96 | $730,758 | $109,085 |
| 2020 | 271 | 675 | 74 | 1.09 | $586,250 | $92,937 |
| 2019 | 50 | 99 | 75 | 0.99 | $99,463 | $18,049 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 85 | $18,282 | $215 |
| New patient visit (45+ min) | 117 | $15,827 | $135 |
| New patient visit (30+ min) | 131 | $11,237 | $86 |
| Removal of external hemorrhoids by rubber banding | 25 | $9,641 | $284 |
| Return visit (30+ min) | 72 | $8,797 | $102 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $7,729 | $203 |
| Biopsy of large bowel using a flexible endoscope | 90 | $7,212 | $80 |
| Diagnostic exam of anus using an endoscope | 44 | $5,659 | $123 |
| Release of scar tissue at ureter | 11 | $4,652 | $423 |
| Injection of hemorrhoid | 13 | $4,547 | $325 |
| Short return visit (20+ min) | 30 | $3,435 | $84 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,475 | $206 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 14 | $306 | $22 |
2022: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 98 | $20,226 | $206 |
| New patient visit (45+ min) | 103 | $14,148 | $137 |
| New patient visit (30+ min) | 165 | $12,961 | $79 |
| Diagnostic exam of large bowel using a flexible endoscope | 64 | $9,576 | $150 |
| Return visit (30+ min) | 69 | $9,407 | $107 |
| Biopsy of large bowel using a flexible endoscope | 114 | $8,258 | $72 |
| Removal of external hemorrhoids by rubber banding | 23 | $7,921 | $283 |
| Diagnostic exam of anus using an endoscope | 47 | $6,319 | $126 |
| Injection of hemorrhoid | 12 | $3,905 | $325 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $3,079 | $62 |
| Short return visit (20+ min) | 23 | $2,030 | $81 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 14 | $277 | $20 |
2021: 12 services
| New patient visit (45+ min) | 104 | $14,002 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $12,274 | $212 |
| New patient visit (30+ min) | 130 | $11,527 | $89 |
| Biopsy of large bowel using a flexible endoscope | 91 | $8,534 | $94 |
| Removal of external hemorrhoids by rubber banding | 19 | $7,143 | $286 |
| Injection of hemorrhoid | 21 | $6,777 | $323 |
| Diagnostic exam of anus using an endoscope | 50 | $6,753 | $123 |
| Return visit (30+ min) | 28 | $3,761 | $107 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,053 | $204 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,899 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,122 | $62 |
| Short return visit (20+ min) | 23 | $2,118 | $81 |
2020: 13 services
| New patient visit (45+ min) | 97 | $13,551 | $140 |
| Injection of hemorrhoid | 30 | $8,860 | $277 |
| New patient visit (30+ min) | 110 | $8,768 | $80 |
| Biopsy of large bowel using a flexible endoscope | 76 | $8,697 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 31 | $6,630 | $214 |
| Removal of external hemorrhoids by rubber banding | 12 | $3,966 | $264 |
| Diagnostic exam of anus using an endoscope | 33 | $3,518 | $103 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,285 | $205 |
| Short return visit (20+ min) | 31 | $2,984 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,221 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,960 | $115 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,642 | $149 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 12 | $1,526 | $117 |
2019: 2 services
| New patient visit (45+ min) | 22 | $3,194 | $145 |
| New patient visit (30+ min) | 22 | $2,063 | $94 |
Drugs they prescribed that Part D paid
$11,987
Pharmacies billed $11,987 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (19 of 179) in 2024. At or below the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 16%.
125 generic and 54 brand-name prescriptions · $11,987 in drug cost · 51 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sutab | 46 | $7,430 | $162 |
| Sod Sulf-Potass Sulf-Mag Sulf | 28 | $1,833 | $65 |
| Neomycin Sulfate | 14 | $70 | $5 |
| Metronidazole | 16 | $34 | $2 |
Year by year
| 2024 | 179 | 112 | 11% (19) | 30% | $11,987 |
| 2023 | 215 | 127 | 7% (16) | 36% | $19,907 |
| 2022 | 167 | 88 | 10% (16) | 35% | $15,195 |
| 2021 | 109 | 55 | 15% (16) | 42% | $13,008 |
| 2020 | 100 | 75 | None | 63% | $9,179 |
| 2019 | 51 | 31 | 41% (21) | None | $453 |
| 2018 | 30 | 20 | 47% (14) | 0% | $265 |
| 2017 | 32 | 27 | 63% (20) | None | $498 |
| 2016 | 17 | None | None | None | $185 |
| 2015 | 12 | None | None | 0% | $107 |
| 2014 | 12 | None | None | None | $459 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Sutab | 48 | $8,060 | $168 |
| Sod Sulf-Potass Sulf-Mag Sulf | 39 | $3,086 | $79 |
| Metronidazole | 24 | $57 | $2 |
2022: 5 drugs
| Sutab | 28 | $4,394 | $157 |
| Clenpiq | 12 | $2,020 | $168 |
| Gabapentin | 23 | $102 | $4 |
| Oxycodone | 11 | $60 | $5 |
| Metronidazole | 16 | $60 | $4 |
2021: 4 drugs
| Linzess | 15 | $7,413 | $494 |
| Sutab | 19 | $2,774 | $146 |
| Suprep | 11 | $1,240 | $113 |
| Metronidazole | 11 | $41 | $4 |
2020: 1 drug
| Suprep | 60 | $6,162 | $103 |
2019: 1 drug
| Tramadol | 12 | $28 | $2 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 17 | $178 | $10 |
Money from drug and device companies
$284 in 2025
| 2025 | 5 | 6 | None | $284 |
| 2024 | 9 | 13 | $1,560 | $1,901 |
| 2023 | 6 | 10 | $5,264 | $5,525 |
| 2022 | 9 | 15 | $5,852 | $6,177 |
| 2021 | 5 | 13 | None | $7,339 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 3 | 6 | None | $391 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Interstim | $165 | 1 payment
|
| Smith+Nephew | Stravix | $47 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $34 | 2 payments
|
| Integra LifeSciences | Integra | $19 | 1 payment
|
| MIMEDX Group | None | $18 | 1 payment
|
See all 6 published payments
| Smith+Nephew | Meals · 2025-12-03 | Stravix | $47 |
| MIMEDX Group | Meals · 2025-09-26 | None | $18 |
| Vertex Pharmaceuticals | Meals · 2025-07-29 | Journavx | $15 |
| Integra LifeSciences | Meals · 2025-06-27 | Integra | $19 |
| Medtronic | Meals · 2025-05-11 | Interstim | $165 |
| Vertex Pharmaceuticals | Meals · 2025-02-25 | Journavx | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,901
| Ethicon | None | $1,583 | 2 payments
|
| Biotissue Holdings | None | $83 | 2 payments
|
| Aroa Biosurgery | None | $70 | 2 payments
|
| Integra LifeSciences | Omnigraft | $53 | 2 payments
|
| SpringWorks Therapeutics | Ogsiveo | $33 | 1 payment
|
| Coloplast | Sensura Mio | $26 | 1 payment
|
| Smith+Nephew | Grafix | $22 | 1 payment
|
| MIMEDX Group | None | $16 | 1 payment
|
| Braintree Laboratories | Suflave | $15 | 1 payment
|
2023: $5,525
| Ethicon | None | $5,347 | 5 payments
|
| Medtronic | Interstim | $96 | 1 payment
|
| Baxter Healthcare | Tisseel | $34 | 1 payment
|
| Smith+Nephew | Stravix | $17 | 1 payment
|
| Trevena | Olinvyk | $16 | 1 payment
|
| Braintree Laboratories | Sutab | $15 | 1 payment
|
2022: $6,177
| Ethicon | None | $5,889 | 5 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $98 | 1 payment
|
| Braintree Laboratories | Sutab | $55 | 2 payments
|
| Heron Therapeutics | Zynrelef | $36 | 2 payments
|
| Ferring Pharmaceuticals | None | $25 | 1 payment
|
| Baxter Healthcare | Tisseel | $22 | 1 payment
|
| Ethicon US | Echelon Flex | $20 | 1 payment
|
| Integra LifeSciences | Surgimend | $19 | 1 payment
|
| Alfasigma USA | None | $12 | 1 payment
|
2021: $7,339
| Intuitive Surgical | Da Vinci Surgical System | $7,239 | 8 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $34 | 1 payment
|
| Braintree Laboratories | Sutab | $30 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $19 | 1 payment
|
| Heron Therapeutics | Zynrelef | $15 | 1 payment
|
2020: $21
| Ferring Pharmaceuticals | Clenpiq | $21 | 1 payment
|
2019: $391
| Braintree Laboratories | Suprep Bowel Prep | $145 | 4 payments
|
| AcelRx Pharmaceuticals | Dsuvia | $123 | 1 payment
|
| Boston Scientific | Resolution Clip | $123 | 1 payment
|
Professional record
- NPI
- 1366799868
- Licence
- CA A128270California A128270: Current · expires 2027-04-30
- Trained
- Tufts University School of Medicine, 2012
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 14850 Los Gatos Blvd, Los Gatos, CA, 95032
- NPI first listed
- 2012-08-14
- NPI last updated
- 2021-05-13
- NPI record certified
- 2021-05-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1000 W Carson St # 461, Torrance, CA, 90502